Serum bicarbonate: can it be a marker of metformin induced acidosis in geriatrics?

S. Rajeshwari, P. Adhikari, M. R. Pai, S. Pemminati, U. P. Rathnakar, R. Pathak

Research output: Contribution to journalArticle

Abstract

Metformin is an oral antidiabetic agent, widely used in the treatment of type 2 diabetes mellitus. The serious side effect of metformin therapy is lactic acidosis. Contraindications for metformin therapy include renal insufficiency. A cut off value of 60 ml/min in creatinine clearance is suggested. Hundred type 2 diabetics receiving metformin as monotherapy or in combination with insulin/other oral antidiabetic agents, were enrolled in the study. Patients were on metformin for atleast one month prior to being enrolled. Patients' demographic data were taken. Baseline serum creatinine and bicarbonate were estimated. Creatinine clearance (Clcr ml/ min) was calculated. Patients were grouped into group 1-4 depending upon the doses of metformin they received. Patients were again grouped based on their Clcr as groupA (Clcr < 60 ml/min), group B (Clcr > 60.01 ml/min). Data was analysed using student's t test. Out of 100 patients 52 were males, 48 females. Mean age and SD of males and females were 69.92 +/- 6.95 and 66.85 +/- 5.72 respectively. Comparison of mean bicarbonate level in different doses of metformin did not show any statistical significance. But comparison of bicarbonate levels based on Clcr were highly statistically significant (p = 0.0084). In three patients whose bicarbonate level was very low (15, 16.4 and 19.2 mmol/L), doses of metformin was reduced and after one month their bicarbonate levels returned to normal (27.4, 25.6 and 26.2 mmol/L). Hence serum bicarbonate can be a marker to assess metformin induced acidosis in geriatrics patients with low creatinine clearance.

Original languageEnglish
Pages (from-to)254-257
Number of pages4
JournalNepal Medical College journal : NMCJ
Volume11
Issue number4
Publication statusPublished - 01-12-2009

Fingerprint

Metformin
Bicarbonates
Acidosis
Geriatrics
Serum
Creatinine
Hypoglycemic Agents
Lactic Acidosis
Type 2 Diabetes Mellitus
Renal Insufficiency
Therapeutics
Demography
Insulin
Students

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Rajeshwari, S., Adhikari, P., Pai, M. R., Pemminati, S., Rathnakar, U. P., & Pathak, R. (2009). Serum bicarbonate: can it be a marker of metformin induced acidosis in geriatrics? Nepal Medical College journal : NMCJ, 11(4), 254-257.
Rajeshwari, S. ; Adhikari, P. ; Pai, M. R. ; Pemminati, S. ; Rathnakar, U. P. ; Pathak, R. / Serum bicarbonate : can it be a marker of metformin induced acidosis in geriatrics?. In: Nepal Medical College journal : NMCJ. 2009 ; Vol. 11, No. 4. pp. 254-257.
@article{ac978f85ac3246cd94830d47681c80c2,
title = "Serum bicarbonate: can it be a marker of metformin induced acidosis in geriatrics?",
abstract = "Metformin is an oral antidiabetic agent, widely used in the treatment of type 2 diabetes mellitus. The serious side effect of metformin therapy is lactic acidosis. Contraindications for metformin therapy include renal insufficiency. A cut off value of 60 ml/min in creatinine clearance is suggested. Hundred type 2 diabetics receiving metformin as monotherapy or in combination with insulin/other oral antidiabetic agents, were enrolled in the study. Patients were on metformin for atleast one month prior to being enrolled. Patients' demographic data were taken. Baseline serum creatinine and bicarbonate were estimated. Creatinine clearance (Clcr ml/ min) was calculated. Patients were grouped into group 1-4 depending upon the doses of metformin they received. Patients were again grouped based on their Clcr as groupA (Clcr < 60 ml/min), group B (Clcr > 60.01 ml/min). Data was analysed using student's t test. Out of 100 patients 52 were males, 48 females. Mean age and SD of males and females were 69.92 +/- 6.95 and 66.85 +/- 5.72 respectively. Comparison of mean bicarbonate level in different doses of metformin did not show any statistical significance. But comparison of bicarbonate levels based on Clcr were highly statistically significant (p = 0.0084). In three patients whose bicarbonate level was very low (15, 16.4 and 19.2 mmol/L), doses of metformin was reduced and after one month their bicarbonate levels returned to normal (27.4, 25.6 and 26.2 mmol/L). Hence serum bicarbonate can be a marker to assess metformin induced acidosis in geriatrics patients with low creatinine clearance.",
author = "S. Rajeshwari and P. Adhikari and Pai, {M. R.} and S. Pemminati and Rathnakar, {U. P.} and R. Pathak",
year = "2009",
month = "12",
day = "1",
language = "English",
volume = "11",
pages = "254--257",
journal = "Nepal Medical College journal : NMCJ",
number = "4",

}

Rajeshwari, S, Adhikari, P, Pai, MR, Pemminati, S, Rathnakar, UP & Pathak, R 2009, 'Serum bicarbonate: can it be a marker of metformin induced acidosis in geriatrics?', Nepal Medical College journal : NMCJ, vol. 11, no. 4, pp. 254-257.

Serum bicarbonate : can it be a marker of metformin induced acidosis in geriatrics? / Rajeshwari, S.; Adhikari, P.; Pai, M. R.; Pemminati, S.; Rathnakar, U. P.; Pathak, R.

In: Nepal Medical College journal : NMCJ, Vol. 11, No. 4, 01.12.2009, p. 254-257.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum bicarbonate

T2 - can it be a marker of metformin induced acidosis in geriatrics?

AU - Rajeshwari, S.

AU - Adhikari, P.

AU - Pai, M. R.

AU - Pemminati, S.

AU - Rathnakar, U. P.

AU - Pathak, R.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Metformin is an oral antidiabetic agent, widely used in the treatment of type 2 diabetes mellitus. The serious side effect of metformin therapy is lactic acidosis. Contraindications for metformin therapy include renal insufficiency. A cut off value of 60 ml/min in creatinine clearance is suggested. Hundred type 2 diabetics receiving metformin as monotherapy or in combination with insulin/other oral antidiabetic agents, were enrolled in the study. Patients were on metformin for atleast one month prior to being enrolled. Patients' demographic data were taken. Baseline serum creatinine and bicarbonate were estimated. Creatinine clearance (Clcr ml/ min) was calculated. Patients were grouped into group 1-4 depending upon the doses of metformin they received. Patients were again grouped based on their Clcr as groupA (Clcr < 60 ml/min), group B (Clcr > 60.01 ml/min). Data was analysed using student's t test. Out of 100 patients 52 were males, 48 females. Mean age and SD of males and females were 69.92 +/- 6.95 and 66.85 +/- 5.72 respectively. Comparison of mean bicarbonate level in different doses of metformin did not show any statistical significance. But comparison of bicarbonate levels based on Clcr were highly statistically significant (p = 0.0084). In three patients whose bicarbonate level was very low (15, 16.4 and 19.2 mmol/L), doses of metformin was reduced and after one month their bicarbonate levels returned to normal (27.4, 25.6 and 26.2 mmol/L). Hence serum bicarbonate can be a marker to assess metformin induced acidosis in geriatrics patients with low creatinine clearance.

AB - Metformin is an oral antidiabetic agent, widely used in the treatment of type 2 diabetes mellitus. The serious side effect of metformin therapy is lactic acidosis. Contraindications for metformin therapy include renal insufficiency. A cut off value of 60 ml/min in creatinine clearance is suggested. Hundred type 2 diabetics receiving metformin as monotherapy or in combination with insulin/other oral antidiabetic agents, were enrolled in the study. Patients were on metformin for atleast one month prior to being enrolled. Patients' demographic data were taken. Baseline serum creatinine and bicarbonate were estimated. Creatinine clearance (Clcr ml/ min) was calculated. Patients were grouped into group 1-4 depending upon the doses of metformin they received. Patients were again grouped based on their Clcr as groupA (Clcr < 60 ml/min), group B (Clcr > 60.01 ml/min). Data was analysed using student's t test. Out of 100 patients 52 were males, 48 females. Mean age and SD of males and females were 69.92 +/- 6.95 and 66.85 +/- 5.72 respectively. Comparison of mean bicarbonate level in different doses of metformin did not show any statistical significance. But comparison of bicarbonate levels based on Clcr were highly statistically significant (p = 0.0084). In three patients whose bicarbonate level was very low (15, 16.4 and 19.2 mmol/L), doses of metformin was reduced and after one month their bicarbonate levels returned to normal (27.4, 25.6 and 26.2 mmol/L). Hence serum bicarbonate can be a marker to assess metformin induced acidosis in geriatrics patients with low creatinine clearance.

UR - http://www.scopus.com/inward/record.url?scp=77955886086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955886086&partnerID=8YFLogxK

M3 - Article

C2 - 20635604

AN - SCOPUS:77955886086

VL - 11

SP - 254

EP - 257

JO - Nepal Medical College journal : NMCJ

JF - Nepal Medical College journal : NMCJ

IS - 4

ER -

Rajeshwari S, Adhikari P, Pai MR, Pemminati S, Rathnakar UP, Pathak R. Serum bicarbonate: can it be a marker of metformin induced acidosis in geriatrics? Nepal Medical College journal : NMCJ. 2009 Dec 1;11(4):254-257.